← Leaderboards
Jonathan F Lovell
State University Of New York At Buffalo
$9,226,863
Attributed
$12,850,670
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,850,670 · 8
By mechanism
R01$8,125,159 · 4
DP5$1,941,400 · 1
R61$1,392,562 · 1
R33$955,150 · 1
R21$436,399 · 1
Top collaborators
- Scott I. Abrams5 shared
- Jean-Philippe Julien5 shared
- Andres Obregon4 shared
- Tracy W Liu1 shared
- Gal Shafirstein1 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Jean-Philippe Julien$1,339,335
- Mark R O'Brian$4,853,299
- Andres Obregon$1,173,856
- Robert M Straubinger$4,875,752
- Jun Qu$2,101,366
Others in their field
Top investigators on “Phospholipids”
- Eugene W. St Clair · Duke University$24,182,181
- Valerian E Kagan · Wistar Institute$23,533,341
- Stanley J Opella · Wistar Institute$22,975,332
- Joel S. Bennett · University Of Pennsylvania$17,733,101
- George M. Carman · Rutgers The St Univ Of Nj New Brunswick$16,801,187
- Daniel E Kahne · Harvard University$16,303,151
Research focus
PhospholipidsLiposomesPorphyrinsSerumResponseToxic EffectBiologicalBaseIn VivoNanotechnologyTumorMolecularParticleDoseCobaltVaccinationBindingDensityFormulationEnvironmentLightDrug Delivery SystemsNanoliposomeAntigens
Grant awards (30)
Developing a Multivalent Subunit Particle Vaccine Against Tuberculosis$955,150
R33 · FY2025 · AI · contact PI
Interstitial Chemophototherapy as an Intervention in Locally Advanced Pancreatic Cancer$677,176
R01 · FY2025 · CA · contact PI
Developing a Multivalent Subunit Particle Vaccine Against Tuberculosis$452,970
R61 · FY2024 · AI · contact PI
Rationally-Designed, Spontaneous-Particleized Pfs48/45 for a Multivalent Malaria Vaccine$392,026
R01 · FY2024 · AI · contact PI
A Cobalt Porphyrin Nanoliposome Adjuvant for MHC-I-Restricted Cancer Peptide Vaccines$359,516
R01 · FY2024 · CA · contact PI
Developing a Multivalent Subunit Particle Vaccine Against Tuberculosis$458,723
R61 · FY2023 · AI · contact PI
Rationally-Designed, Spontaneous-Particleized Pfs48/45 for a Multivalent Malaria Vaccine$455,639
R01 · FY2023 · AI · contact PI
A Cobalt Porphyrin Nanoliposome Adjuvant for MHC-I-Restricted Cancer Peptide Vaccines$370,870
R01 · FY2023 · CA · contact PI
Developing a Multivalent Subunit Particle Vaccine Against Tuberculosis$480,869
R61 · FY2022 · AI · contact PI
Rationally-Designed, Spontaneous-Particleized Pfs48/45 for a Multivalent Malaria Vaccine$392,026
R01 · FY2022 · AI · contact PI
A Cobalt Porphyrin Nanoliposome Adjuvant for MHC-I-Restricted Cancer Peptide Vaccines$370,870
R01 · FY2022 · CA · contact PI
Chemophototherapy with Porphyrin-phospholipid Liposomes Permeabilized by Red Light$492,918
R01 · FY2021 · EB · contact PI
Rationally-Designed, Spontaneous-Particleized Pfs48/45 for a Multivalent Malaria Vaccine$392,026
R01 · FY2021 · AI · contact PI
A Cobalt Porphyrin Nanoliposome Adjuvant for MHC-I-Restricted Cancer Peptide Vaccines$378,438
R01 · FY2021 · CA · contact PI
Chemophototherapy with Porphyrin-phospholipid Liposomes Permeabilized by Red Light$593,755
R01 · FY2020 · EB · contact PI
Rationally-Designed, Spontaneous-Particleized Pfs48/45 for a Multivalent Malaria Vaccine$492,238
R01 · FY2020 · AI · contact PI
A Cobalt Porphyrin Nanoliposome Adjuvant for MHC-I-Restricted Cancer Peptide Vaccines$393,352
R01 · FY2020 · CA · contact PI
Chemophototherapy with Porphyrin-phospholipid Liposomes Permeabilized by Red Light$595,767
R01 · FY2019 · EB · contact PI
Chemophototherapy with Porphyrin-phospholipid Liposomes Permeabilized by Red Light$422,405
R01 · FY2018 · EB · contact PI
Targeting Tumors with Resealable Nanovesicles Permeabilized by NIR Light$386,765
DP5 · FY2017 · OD · contact PI
A His-tag Binding Membrane System for Generating Neutralizing Gp41 MPER antibodies$238,115
R21 · FY2017 · AI · contact PI
Targeting Tumors with Resealable Nanovesicles Permeabilized by NIR Light$387,847
DP5 · FY2016 · OD · contact PI
Light-Triggered Drug Release in Primed Pancreatic Tumors$341,490
R01 · FY2016 · EB · contact PI
A His-tag Binding Membrane System for Generating Neutralizing Gp41 MPER antibodies$198,284
R21 · FY2016 · AI · contact PI
Targeting Tumors with Resealable Nanovesicles Permeabilized by NIR Light$388,843
DP5 · FY2015 · OD · contact PI
Light-Triggered Drug Release in Primed Pancreatic Tumors$334,565
R01 · FY2015 · EB · contact PI
Targeting Tumors with Resealable Nanovesicles Permeabilized by NIR Light$388,569
DP5 · FY2014 · OD · contact PI
Light-Triggered Drug Release in Primed Pancreatic Tumors$316,942
R01 · FY2014 · EB · contact PI
Targeting Tumors with Resealable Nanovesicles Permeabilized by NIR Light$389,376
DP5 · FY2013 · OD · contact PI
Light-Triggered Drug Release in Primed Pancreatic Tumors$353,140
R01 · FY2013 · EB · contact PI